Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Barry A Singer

6PUBLICATIONS
14CO-AUTHORS
Regenerative medicine (incl. stem cells)Gene and molecular therapyMedical virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Feb 12, 2025
Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study.

Tjalf Ziemssen, Ann D Bass, Bart Van Wijmeersch

|Sep 04, 2024
Patient and Physician Perspectives of Treatment Burden in Multiple Sclerosis.

Barry A Singer, Dawn Morgan, Julie A Stamm

|Jun 27, 2024
Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study.

Barry A Singer, Sibyl Wray, Mark Gudesblatt

|Apr 14, 2024
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption.

Barry A Singer, Jenny Feng, Horacio Chiong-Rivero

|Sep 25, 2023
Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study.

Alasdair J Coles, Anat Achiron, Anthony Traboulsee

|May 20, 2021
A Study Comparing Patient and Clinician Perspectives of Treatments for Multiple Sclerosis via Group Concept Mapping.

Barry A Singer, Shannon Keith, Amy Howerter

Pageof 1

Frequent Collaborators

3 joint publications

Tjalf Ziemssen

1 joint publications

Amy Howerter

1 joint publications

Helen Doll

1 joint publications

Alasdair J Coles

1 joint publications

Anat Achiron

1 joint publications

Carlo Pozzilli

1 joint publications

Gavin Giovannoni

1 joint publications

Jenny Feng

1 joint publications

Horacio Chiong-Rivero

1 joint publications

Mark Gudesblatt

Frequent Collaborators

3 joint publications

Tjalf Ziemssen

1 joint publications

Amy Howerter

1 joint publications

Helen Doll

1 joint publications

Alasdair J Coles

Top Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on : Sep 09, 2022

3.4K
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on : Jun 30, 2014

57.9K
See more related videos

Top Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on : Sep 09, 2022

3.4K
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on : Jun 30, 2014

57.9K
See more related videos